Public Health

WASHINGTON — America’s most celebrated infrastructure initiative, the interstate highway system, rammed an elevated freeway through the center of Claiborne Avenue in New Orleans in the late 1960s.

Country / Region Tags:

United States

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Some poor countries can’t cover the cost of administering the coronavirus vaccines when they finally receive them

Fri, 2021-04-02 09:36 — mike kraft

Coronavirus vaccines are finally reaching poor countries, but some can’t cover the cost of administering them Public health experts told The Post that many low-income countries are on track to face acute shortages of trained and salaried health-care workers in a few months, when Covax shipments increase. Miriam Berger Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Ontario provience will enter a third lock down because of increasing COVID-19 cases

Thu, 2021-04-01 20:36 — mike kraft

Ontario 'pulling the emergency brake' with third COVID-19 lockdown as cases rise, ICU beds fill The Canadian province of Ontario will enter a limited lockdown for 28 days on Saturday, as COVID-19 cases and hospitalizations rise and more dangerous virus variants take hold, the premier said on Thursday. Allison Martell, Moira Warburton U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ontario provience will enter a third lock down because of increasing COVID-19 cases
Log in or register to post comments

OPINION: How Europe has mishandled the pandemic--The Economist

Thu, 2021-04-01 19:58 — mike kraft

How Europe has mishandled the pandemic What happened and what does it mean for the union? The Economist

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about OPINION: How Europe has mishandled the pandemic--The Economist
Log in or register to post comments

U.S. at a pivitol point with a fourth wave of COVID-19

Thu, 2021-04-01 19:19 — mike kraft

The fourth COVID-19 wave is here Cases are up 17% over last week. Sam Baker,Andrew Witherspoon Axios

The big picture: America may be at the beginning of a fourth wave in the pandemic. It will almost certainly be far less deadly than the previous three, but this persistent failure to contain the virus has real consequences, and will only make it harder to put COVID-19 behind us.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. at a pivitol point with a fourth wave of COVID-19
Log in or register to post comments

Overview"Coronavirus international developments briefs

Thu, 2021-04-01 11:20 — mike kraft

Factbox-Latest on the worldwide spread of the coronavirus The World Trade Organization said risks from the uneven roll-out of coronavirus vaccination campaigns and the possible emergence of vaccine-resistant strains clouded the outlook for the global trade in goods, while raising its growth forecast slightly. Reuters Staff U.S.

...

* All health workers in Italy must have coronavirus jabs, the government said, in a potentially controversial move aimed at protecting vulnerable patients and pushing back against ‘no-vax’ sentiment.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview"Coronavirus international developments briefs
Log in or register to post comments

FDA Approves 2 Rapid COVID Tests for at home use

Thu, 2021-04-01 09:30 — mike kraft

More consumers will soon be able to test themselves for COVID-19 from the comfort of their own home. On Wednesday, the Food and Drug Administration approved two rapid antigen home tests for use in the U.S.

Americans will soon be able to purchase Abbott's BinaxNOW and Quidel Quickvue tests at drug stores. The two options join a test made by Ellume, which received FDA approval in December, in the market. The two, newly-approved swab tests will be sold at a lower price point.

The BinaxNOW and Quickvue tests are expected to be sold in two-packs for around $15-20; Ellume costs $30.

Country / Region Tags:

General Topic Tags: